Although this is the first trial of narrowband UVB phototherapy for CIS, in people with psoriasis for whom this treatment has been a mainstay, UVB exposure decreases the levels in skin of inflammatory cytokines such as TNF-α, IFN-γ, and IL-17, that may influence B cell maturation21–23. Here, IL17A is linked to psoriasis.